Join
Live feed
·
SECFilingvia Quantisnow
Arbutus Biopharma Corporation logo

Amendment: SEC Form SCHEDULE 13G/A filed by Arbutus Biopharma Corporation

ByQuantisnow·Wall Street's wire, on your screen.
ABUS· Arbutus Biopharma Corporation
Health Care
Full content unavailable. See the original source below.
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABUS (Arbutus Biopharma Corporation) and more on Quantisnow.